ClinConnect ClinConnect Logo
Search / Trial NCT05650190

Spectacle Lens Visual Acuity Assessments Study

Launched by SIGHTGLASS VISION, INC. · Dec 6, 2022

Trial Information

Current as of July 30, 2025

Active, not recruiting

Keywords

ClinConnect Summary

The Spectacle Lens Visual Acuity Assessments Study is looking at how well certain glasses can help improve vision in children and young adults with myopia (nearsightedness). This study is specifically for participants who are already part of another study called the CYPRESS Extension. If you or your child is between the ages of 8 and 15, and you have already been involved in that study, you might be eligible to take part in this trial.

Participants will undergo some extra tests to see how well they can see while wearing different lenses. It's important that the child's parent or legal guardian is on board and understands the study by signing a consent form. However, if the child has any current eye infections or issues that could affect their vision, they won't be able to participate. Overall, this study aims to gather more information about visual performance in young people with myopia.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Existing subject from the CYPRESS Extension study (CPRO-1802-002)
  • Ability to comply with study assessments
  • The subject's parent(s) or legal guardian(s) must read, understand and sign the Statement of Informed Consent and receive a fully executed coy of the form
  • Exclusion Criteria:
  • Any current ocular infection, inflammation or irritation likely to affect vision

About Sightglass Vision, Inc.

SightGlass Vision, Inc. is a pioneering clinical trial sponsor dedicated to advancing innovative solutions for the treatment of myopia and other vision-related conditions. With a focus on developing cutting-edge optical devices and therapies, the company is committed to enhancing patient outcomes through rigorous research and evidence-based practices. Leveraging a team of experienced professionals and a robust clinical development framework, SightGlass Vision aims to bring transformative products to market that address the growing global challenge of myopia, ultimately improving the quality of life for individuals affected by vision impairments.

Locations

Pittsburg, Kansas, United States

Longwood, Florida, United States

Salt Lake City, Utah, United States

New York, New York, United States

Raytown, Missouri, United States

Houston, Texas, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials